Nuvisan Takes Over Nestlé Skin Health’s R&D

Author Image

By: TOM BRANNA

Editor

FRANCE: The Nuvisan Group, a European CRO focused on early stage drug development for the life science industry, has signed an agreement with Nestlé Skin Health/Galderma to take over parts of the R&D capacities in Sophia-Antipolis, France. The Galderma R&D site in Sophia-Antipolis, open since 2006, is one of the world’s largest research and development centers focused on medical and cosmetic solutions for the skin. The new capabilities will strengthen Nuvisan’s core service lines in...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters